Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
ASSETS
Cash and due from banks, including interest bearing amounts of $751,249 and $425,866, respectively	$ 956,109	$ 568,137
Securities:
Equity securities, at fair value	30,809	13,427
Available-for-sale debt securities, at fair value	3,288,332	2,246,072
Held-to-maturity debt securities (fair values of $1,035,957 and $1,006,817, respectively)	1,132,114	1,152,906
Allowance for credit losses, held-to-maturity debt securities	(168)	(146)
Net held-to-maturity debt securities	1,131,946	1,152,760
Total securities	4,451,087	3,412,259
Loans held for sale	87,454	18,695
Portfolio loans, net of unearned income	19,226,432	12,656,429
Allowance for credit losses - loans	(218,749)	(138,766)
Net portfolio loans	19,007,683	12,517,663
Premises and equipment, net	263,240	219,076
Accrued interest receivable	106,651	78,324
Goodwill and other intangible assets, net	1,723,385	1,124,016
Bank-owned life insurance	557,512	360,738
Other assets	543,212	385,390
Total Assets	27,696,333	18,684,298
Deposits:
Non-interest bearing demand	5,376,767	3,842,758
Interest bearing demand	5,186,880	3,771,314
Money market	5,072,039	2,429,977
Savings deposits	3,157,782	2,362,736
Certificates of deposit	2,875,372	1,726,932
Total deposits	21,668,840	14,133,717
Federal Home Loan Bank borrowings	1,200,000	1,000,000
Other short-term borrowings	110,679	192,073
Subordinated debt and junior subordinated debt	308,529	279,308
Total borrowings	1,619,208	1,471,381
Accrued interest payable	19,150	14,228
Other liabilities	357,222	274,691
Total Liabilities	23,664,420	15,894,017
SHAREHOLDERS’ EQUITY
Common stock, $2.0833 par value; 200,000,000 shares authorized; 96,067,559 and 75,354,034 shares issued; 96,067,559 and 66,919,805 shares outstanding at December 31, 2025 and December 31, 2024, respectively	200,137	156,985
Capital surplus	2,490,440	1,809,679
Retained earnings	1,252,765	1,192,091
Treasury stock (0 and 8,434,229 shares at cost, respectively)	0	(292,244)
Accumulated other comprehensive loss	(133,320)	(218,632)
Deferred benefits for directors	(2,296)	(2,082)
Total Shareholders’ Equity	4,031,913	2,790,281
Total Liabilities and Shareholders’ Equity	27,696,333	18,684,298
Series A Preferred Stock [Member]
SHAREHOLDERS’ EQUITY
Preferred stock	0	144,484
Series B Preferred Stock [Member]
SHAREHOLDERS’ EQUITY
Preferred stock	$ 224,187	$ 0